Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Neovacs    ALNEV   FR0004032746

NEOVACS (ALNEV)

Delayed Quote. Delayed  - 05/27 05:35:27 pm
1.15 EUR   +0.88%
05/17 NEOVACS : to attend ChinaBio® Event May 18 & 19, 2016
05/12 NEOVACS : and Stellar Biotechnologies sign joint venture agreement t..
04/29 NEOVACS : obtains FDA approval to extend its Phase IIb clinical tria..
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
1.13(c) 1.13(c) 1.14(c) 1.14(c) 1.15(c) Last
531 484 85 665 151 811 369 242 234 242 Volume
0.00% 0.00% +0.88% 0.00% +0.88% Change
More quotes
Financials (€)
Sales 2016 0,20 M
EBIT 2016 -10,5 M
Net income 2016 -7,90 M
Debt 2016 -
Yield 2016 -
Sales 2017 0,20 M
EBIT 2017 -12,5 M
Net income 2017 -9,90 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 190x
Capi. / Sales 2017 190x
Capitalization 38,1 M
More Financials
Company
Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory, and cancerous diseases.It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis, and... 
More about the company
Latest news on NEOVACS
05/17 DGAP-NEWS : Neovacs to attend ChinaBio(R) Event May 18 & 19, 2016
05/17 NEOVACS : to attend ChinaBio® Event May 18 & 19, 2016
05/12 NEOVACS : and Stellar Biotechnologies sign joint venture agreement to create Neo..
05/12 DGAP-NEWS : Neovacs and Stellar Biotechnologies sign a joint venture agreement t..
04/29 NEOVACS : obtains FDA approval to extend its Phase IIb clinical trial in Lupus t..
04/28 NEOVACS : obtains FDA approval to extend its Phase IIb clinical trial in Lupus t..
04/28 DGAP-NEWS : Neovacs obtains FDA approval to extend its Phase IIb clinical trial ..
04/14 NEOVACS : OBTAINS SOUTH KOREA HEALTH AUTHORITY APPROVAL FOR IND APPLICATION WITH..
03/21 NEOVACS : Will attend the 2016 european smallcap event
03/07 NEOVACS : Reports full year 2015 financial results
More news
Sector news : Biotechnology & Medical Research - NEC
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
05/27 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm ..
05/27 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Scien..
05/27 MEDIVATION : Files Preliminary Consent Revocation Statement
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart NEOVACS
Duration : Period :
Neovacs Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials